12. Congenital myasthenic syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 5 / Drugs : 7 - (DrugBank : 3) / Drug target genes : 5 - Drug target pathways : 13
Congenital myasthenic syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 12 | Congenital myasthenic syndrome |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 6 | Parkinson disease |
| 11 | Myasthenia gravis |
| 3 | Spinal muscular atrophy |
| 14 | Chronic inflammatory demyelinating polyneuropathy |
| 4 | Primary lateral sclerosis |
| 111 | Congenital myopathy |